Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse
- PMID: 15678083
- PMCID: PMC1576051
- DOI: 10.1038/sj.bjp.0706109
Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse
Abstract
1. To gain further insight into the mechanisms underlying the antihyperalgesic and antiallodynic actions of gabapentin, a chronic pain model was prepared by partially ligating the sciatic nerve in mice. The mice then received systemic or local injections of gabapentin combined with either central noradrenaline (NA) depletion by 6-hydroxydopamine (6-OHDA) or alpha-adrenergic receptor blockade. 2. Intraperitoneally (i.p.) administered gabapentin produced antihyperalgesic and antiallodynic effects that were manifested by elevation of the withdrawal threshold to a thermal (plantar test) or mechanical (von Frey test) stimulus, respectively. 3. Similar effects were obtained in both the plantar and von Frey tests when gabapentin was injected intracerebroventricularly (i.c.v.) or intrathecally (i.t.), suggesting that it acts at both supraspinal and spinal loci. This novel supraspinal analgesic action of gabapentin was only obtained in ligated neuropathic mice, and gabapentin (i.p. and i.c.v.) did not affect acute thermal and mechanical nociception. 4. In mice in which central NA levels were depleted by 6-OHDA, the antihyperalgesic and antiallodynic effects of i.p. and i.c.v. gabapentin were strongly suppressed. 5. The antihyperalgesic and antiallodynic effects of systemic gabapentin were reduced by both systemic and i.t. administration of yohimbine, an alpha2-adrenergic receptor antagonist. By contrast, prazosin (i.p. or i.t.), an alpha1-adrenergic receptor antagonist, did not alter the effects of gabapentin. 6. It was concluded that the antihyperalgesic and antiallodynic effects of gabapentin are mediated substantially by the descending noradrenergic system, resulting in the activation of spinal alpha2-adrenergic receptors.
Figures









Similar articles
-
Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.Br J Pharmacol. 2006 May;148(2):233-44. doi: 10.1038/sj.bjp.0706731. Br J Pharmacol. 2006. PMID: 16582934 Free PMC article.
-
Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model.Neuropharmacology. 2007 Dec;53(7):842-53. doi: 10.1016/j.neuropharm.2007.08.013. Epub 2007 Aug 19. Neuropharmacology. 2007. PMID: 17889907
-
Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury.Eur J Pharmacol. 2007 Feb 5;556(1-3):69-74. doi: 10.1016/j.ejphar.2006.10.059. Epub 2006 Nov 3. Eur J Pharmacol. 2007. PMID: 17141754
-
Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury.J Neurosci Res. 2008 Nov 15;86(15):3258-64. doi: 10.1002/jnr.21786. J Neurosci Res. 2008. PMID: 18655202 Review.
-
[Alpha2-adrenergic receptors in the dorsal horn of the spinal cord--their function and the descending inhibitory systems].Masui. 2007 Nov;56 Suppl:S161-71. Masui. 2007. PMID: 18051461 Review. Japanese. No abstract available.
Cited by
-
Nitrous oxide persistently alleviates pain hypersensitivity in neuropathic rats: A dose-dependent effect.Pain Res Manag. 2015 Nov-Dec;20(6):309-15. doi: 10.1155/2015/809059. Epub 2015 Sep 15. Pain Res Manag. 2015. PMID: 26371891 Free PMC article.
-
Antinociceptive activity of methanol extract of Chlorophytum alismifolium tubers in murine model of pain: Possible involvement of α2-adrenergic receptor and KATP channels.J Tradit Complement Med. 2019 Mar 16;10(1):1-6. doi: 10.1016/j.jtcme.2019.03.005. eCollection 2020 Jan. J Tradit Complement Med. 2019. PMID: 31956552 Free PMC article.
-
Current Status of the New Antiepileptic Drugs in Chronic Pain.Front Pharmacol. 2016 Aug 25;7:276. doi: 10.3389/fphar.2016.00276. eCollection 2016. Front Pharmacol. 2016. PMID: 27610084 Free PMC article. Review.
-
Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse.Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):107-14. doi: 10.1007/s00210-005-0006-5. Epub 2005 Oct 22. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 16217643
-
The posterior hypothalamus exerts opposing effects on nociception via the A7 catecholamine cell group in rats.Neuroscience. 2012 Dec 27;227:144-53. doi: 10.1016/j.neuroscience.2012.09.058. Epub 2012 Oct 2. Neuroscience. 2012. PMID: 23036619 Free PMC article.
References
-
- ARNER S., MEYERSON B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988;33:11–23. - PubMed
-
- BACKONJA M., BEYDOUN A., EDWARDS K.R., SCHWARTZ S.L., FONSECA V., HES M., LAMOREAUX L., GAROFALO E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J. Am. Med. Assoc. 1998;280:1831–1836. - PubMed
-
- BAYER K., AHMADI S., ZEILHOFER H.U. Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology. 2004;46:743–749. - PubMed
-
- BERTRAND S., NG G.Y.K., PURISAI M.G., WOLFE S.E., SEVERIDT M.W., NOUEL D., ROBITAILLE R., LOW M.J., O'NEILL G.P., METTERS K., LACAILLE J.C., CHRONWALL B.M., MORRIS S.J. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain γ-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J. Pharmacol. Exp. Ther. 2001;298:15–24. - PubMed
-
- CHAPLAN S.R., BACH F.W., POGREL J.W., CHUNG J.M., YAKSH T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 1994;53:55–63. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources